|
gptkbp:instanceOf
|
gptkb:analgesic
gptkb:antitussive
gptkb:opioid_medication
|
|
gptkbp:activeIngredient
|
gptkb:codeine
|
|
gptkbp:affiliatedWith
|
opioids
phenanthrenes
|
|
gptkbp:ATCCode
|
R05DA04
|
|
gptkbp:brand
|
Codeine Contin
Codeine Phosphate Tablets
|
|
gptkbp:CASNumber
|
41444-62-6
|
|
gptkbp:cause
|
tolerance
vomiting
dizziness
itching
allergic reaction
hypotension
euphoria
urinary retention
dependence
miosis
dysphoria
|
|
gptkbp:chemicalFormula
|
C18H24NO7P
|
|
gptkbp:contraindication
|
asthma
respiratory depression
children under 12
|
|
gptkbp:controlledSubstanceSchedule
|
Schedule III (US, in combination)
Schedule II (US, when alone)
|
|
gptkbp:discoveredBy
|
gptkb:Pierre_Jean_Robiquet
|
|
gptkbp:discoveredIn
|
1832
|
|
gptkbp:eliminationHalfLife
|
2.5–4 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:interactsWith
|
gptkb:beer
CYP2D6 inhibitors
other CNS depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB00318
5284371
|
|
gptkbp:riskFactor
|
addiction
overdose
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
constipation
drowsiness
respiratory depression
|
|
gptkbp:UNII
|
8L70Q75FXE
|
|
gptkbp:usedFor
|
pain relief
cough suppression
|
|
gptkbp:bfsParent
|
gptkb:Co-codaprin
gptkb:Tylenol_#4
gptkb:Nurofen_Plus
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
codeine phosphate
|